Skip to content

MDSH: what changed

BE 0823.924.136NACE 72.101, Research and development on biotechnologyOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€3,314
2024 · €68,596-€65,282
Equity
€82,373
2024 · €82,856-€483
Cash
€84,776
2024 · €88,381-€3,604
Balance sheet total
€92,229
2024 · €88,523+€3,706

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€4,421

    up €4,421 (+3,756%), from €118 to €4,538

    of which Trade receivables: +€4,538

  • Cash -€3,604

    down €3,604 (-4.1%), from €88,381 to €84,776

    mainly Receivables within one year (-€4,421) and Contributions, distributions and other (-€3,797)

  • Deferred charges and accrued income +€1,575

    new in 2025: €1,575

  • Tangible fixed assets +€1,314

    new in 2025: €1,314

Equity and liabilities
  • Other debts +€7,589

    up €7,589 (+1,231%), from €617 to €8,205

  • Profit (loss) carried forward -€7,096

    no longer reported in 2025 (was €7,096)

  • Reserves +€6,613

    up €6,613 (+10.4%), from €63,360 to €69,973

  • Tax, wage and social debts -€3,417

    down €3,417 (-67.7%), from €5,051 to €1,633

Income statement
  • Gross operating margin -€90,151

    down €90,151 (-95.6%), from €94,343 to €4,192

  • Taxes -€25,023

    down €25,023 (-99.9%), from €25,060 to €36

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €68,596
Gross operating margin -€90,151
Depreciation +€47
Other operating charges -€12
Financial income -€15
Financial charges -€174
Taxes +€25,023
Result 2025 €3,314
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€1,556
Investment -€1,364
Financing -€3,797
Cash 2024 €88,381
Net result for the year +€3,314
Depreciation +€50
Receivables within one year -€4,421
Deferred charges and accrued income -€1,575
Trade debts +€17
Tax, wage and social debts -€3,417
Other debts +€7,589
Investment in fixed assets (net) -€1,364
Contributions, distributions and other -€3,797
Cash 2025 €84,776
brings cash intakes cash out
Every line side by side 37 lines
Line Code 2024 2025 Change %
Total assets 20/58 €88,523 €92,229 +€3,706 +4.2%
Fixed assets 21/28 €25 €1,339 +€1,314 +5,256%
Tangible fixed assets 22/27 - €1,314 +€1,314
Plant, machinery and equipment 23 - €1,314 +€1,314
Financial fixed assets 28 €25 €25 = 0.0%
Current assets 29/58 €88,498 €90,890 +€2,392 +2.7%
Amounts receivable within one year 40/41 €118 €4,538 +€4,421 +3,756%
Trade receivables 40 - €4,538 +€4,538
Other amounts receivable 41 €118 - -€118
Cash at bank and in hand 54/58 €88,381 €84,776 -€3,604 -4.1%
Deferred charges and accrued income 490/1 - €1,575 +€1,575
Total equity and liabilities 10/49 €88,523 €92,229 +€3,706 +4.2%
Equity 10/15 €82,856 €82,373 -€483 -0.6%
Contributions 10/11 €12,400 €12,400 = 0.0%
Reserves 13 €63,360 €69,973 +€6,613 +10.4%
Distributable reserves 133 €63,360 €69,973 +€6,613 +10.4%
Profit (loss) carried forward 14 €7,096 - -€7,096
Amounts payable 17/49 €5,667 €9,856 +€4,188 +73.9%
Amounts payable within one year 42/48 €5,667 €9,856 +€4,188 +73.9%
Trade debts 44 - €17 +€17
Suppliers 440/4 - €17 +€17
Taxes, remuneration and social security 45 €5,051 €1,633 -€3,417 -67.7%
Taxes 450/3 €5,051 €1,633 -€3,417 -67.7%
Other amounts payable 47/48 €617 €8,205 +€7,589 +1,231%
Non-recurring operating income 76A - €250 +€250
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €96 €50 -€47 -48.3%
Other operating charges 640/8 €387 €400 +€12 +3.2%
Gross operating margin 9900 €94,343 €4,192 -€90,151 -95.6%
Operating profit (loss) 9901 €93,860 €3,743 -€90,117 -96.0%
Financial income 75/76B €29 €15 -€15 -50.3%
Recurring financial income 75 €29 €15 -€15 -50.3%
Financial charges 65/66B €233 €407 +€174 +74.5%
Recurring financial charges 65 €233 €407 +€174 +74.5%
Profit (loss) for the period before taxes 9903 €93,656 €3,350 -€90,306 -96.4%
Income taxes 67/77 €25,060 €36 -€25,023 -99.9%
Profit (loss) for the period 9904 €68,596 €3,314 -€65,282 -95.2%
Profit (loss) for the period to be appropriated 9905 €68,596 €3,314 -€65,282 -95.2%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€284,583 to €381,942

Midpoint €325,149 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Adjusted equity €82,373
Capitalised earnings €486,793 to €681,510
Indication €284,583 to €381,942

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€82,373
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€82,373

Capitalised earnings

net result for the year (9904)
2025
€3,314
excluding non-recurring income and charges
€3,064
2024
€68,596
2023
€132,792
2022
€115,609
2021
€99,845
Average result, excluding non-recurring income and charges
€68,151
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€486,793 / €567,925 / €681,510

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 14 November 2026 via checked.be.